Print

Purpose

The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.

Condition

Eligibility

Eligible Ages
Between 50 Years and 75 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Have a home address and access to a working telephone - Pass Mini-Cog assessment

Exclusion Criteria

  • FIT (fecal immunochemical test) test within 1 year, Sigmoidoscopy or Barium enema within 5 years, or Colonoscopy within 10 years - Acute medical illness, - current GI bleed - history of adenomatous polyps - Colorectal Cancer - 1st degree relative with CRC < age 60 years - inherited polyposis/non-polyposis syndrome - inflammatory bowel disease - Another household member enrolled in the study

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Double (Participant, Care Provider)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
HE + HE 		Participants receive up to two interventions. Participants receive HE initially and then a second time if not screened after 6 months.
  • Other: Health Education
    Standard of care approach that will provide basic information on CRC screening.
Active Comparator
HE + I2 		Participants receive up to two interventions. Participants receive HE initially and then I2 if not screened after 6 months.
  • Other: I2
    A touch screen computer delivered "implementation intentions" (I2) intervention on CRC screening. "Implementation intentions" are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).
    Other names:
    • Implementation Intentions
  • Other: Health Education
    Standard of care approach that will provide basic information on CRC screening.
Experimental
I2 + I2 		Participants receive up to two interventions. Participants receive I2 initially and then a second time if not screened after 6 months.
  • Other: I2
    A touch screen computer delivered "implementation intentions" (I2) intervention on CRC screening. "Implementation intentions" are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).
    Other names:
    • Implementation Intentions
Active Comparator
I2 + HE 		Participants receive up to two interventions. Participants receive I2 initially and then HE if not screened after 6 months.
  • Other: I2
    A touch screen computer delivered "implementation intentions" (I2) intervention on CRC screening. "Implementation intentions" are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).
    Other names:
    • Implementation Intentions
  • Other: Health Education
    Standard of care approach that will provide basic information on CRC screening.

Recruiting Locations

University of Kansas Medical Center
Kansas City, Kansas 66160

More Details

Status
Unknown status
Sponsor
University of Kansas Medical Center

Study Contact

Angela Watson, MBA
(913) 945-6675
awatson@kumc.edu

Detailed Description

Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.